Exelixis Inc

EXEL

Market Cap$6.87B

Close$

Compare Exelixis

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Exelixis Inc	33.1	0%	9%	3.7	-
Market Avg	59.7	1.27%	30%	-	0.9
Healthcare Avg	64.5	1.29%	15%	7.1	0.8

$25.00

Target Price by Analysts

11.2% upsideExelixis Target Price Details

$55.58

Current Fair Value

147.1% upside

Undervalued by 147.1% based on the discounted cash flow analysis.

Share Statistics

Market cap	$6.87 Billion
Enterprise Value	$5.87 Billion
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$0.65
Beta	0.14
Outstanding Shares	303,194,259
Avg 30 Day Volume	2,243,583

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	33.05
PEG	-8.62
Price to Sales	3.75
Price to Book Ratio	3.21
Enterprise Value to Revenue	3.21
Enterprise Value to EBIT	34.36
Enterprise Value to Net Income	28
Total Debt to Enterprise	0
Debt to Equity	0

Revenue Sources

No data

ESG Score

No data

About Exelixis Inc